documents: FDA-1992-E-0012-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1992-E-0012-0002 FDA FDA-1992-E-0012 Determination of Regulatory Review Period for Purposes of Patent Extension; Supprelin; Correction Notice Correction 1994-05-26T04:00:00Z 1994 5     2023-09-25T11:46:30Z 94-9047 0 0 0900006480526109

Links from other tables